Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

@article{Lee2004DialysisdependentRF,
  title={Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant},
  author={C Lee and Maurizio Zangari and Bart Barlogie and Athanasios Fassas and Frits van Rhee and Raymond Thertulien and Giampaolo Talamo and Firas Muwalla and Elias Anaissie and Klaus Hollmig and Guido Tricot},
  journal={Bone Marrow Transplantation},
  year={2004},
  volume={33},
  pages={823-828}
}
Summary:To evaluate the role of high-dose melphalan and autologous transplant (AT) in reversing dialysis-dependent renal failure, 59 patients still on dialysis at the time of AT were analyzed. A total of 37 patients had been on dialysis ⩽6 months. A 5-year event-free and overall survival rate of all patients after AT was 24 and 36%, respectively. Of 54… CONTINUE READING